Viewing Study NCT07243002


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-01-10 @ 2:06 PM
Study NCT ID: NCT07243002
Status: RECRUITING
Last Update Posted: 2025-12-23
First Post: 2025-11-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters.
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module